Cary Street Partners Investment Advisory LLC Halozyme Therapeutics, Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $2.63 Billion
- Q3 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 120,134 shares of HALO stock, worth $6.82 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
120,134
Previous 20,248
493.31%
Holding current value
$6.82 Million
Previous $1.06 Million
548.3%
% of portfolio
0.26%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding HALO
# of Institutions
534Shares Held
123MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$732 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$377 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$231 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$193 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.91B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...